Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Dideoxyadenosine MeSH Descriptor Data 2025


MeSH Heading
Dideoxyadenosine
Tree Number(s)
D03.633.100.759.590.138.325.105
D13.570.230.229.105
D13.570.230.500.105
D13.570.583.138.325.105
Unique ID
D016048
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016048
Annotation
an antiviral; inhibits HIV replication
Scope Note
A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is an inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal side effect is nephrotoxicity. In vivo, dideoxyadenosine is rapidly metabolized to DIDANOSINE (ddI) by enzymatic deamination; ddI is then converted to dideoxyinosine monophosphate and ultimately to dideoxyadenosine triphosphate, the putative active metabolite.
Entry Term(s)
2',3'-Dideoxyadenosine
ddA (Antiviral)
Pharm Action
Antimetabolites
Antiviral Agents
Registry Numbers
4Q86AH641A
Related Numbers
4097-22-7
CAS Type 1 Name
Adenosine, 2',3'-dideoxy-
Previous Indexing
Deoxyadenosine/analogs & derivatives (1975-1989)
Dideoxynucleosides (1989)
Public MeSH Note
90
History Note
90
Date Established
1990/01/01
Date of Entry
1989/07/14
Revision Date
2016/05/31
Dideoxyadenosine Preferred
page delivered in 0.141s